Literature DB >> 9580591

Gender differences in the expression of endothelin receptors in human saphenous veins in vitro.

A Ergul1, K Shoemaker, D Puett, R L Tackett.   

Abstract

The contractile response to endothelin-1 (ET-1) appears to be modulated by the relative density of ETA and ETB receptors. To determine the effects of gender on the distribution of ET receptors, we analyzed the endothelin receptor subtypes on membrane fractions prepared from saphenous vein samples obtained from patients of different genders undergoing coronary artery bypass graft surgery. The contractile response to ET-1 in the presence and absence of 1 microM of the ETA receptor antagonist BQ-123 was also investigated. Similar studies were repeated with endothelium-denuded samples to study the role of endothelium- and smooth muscle-derived ETB receptors. Competitive binding experiments were performed on membrane fractions using [125I]ET-1 and unlabeled ligands ET-1, ET-3, sarafatoxin 6c and BQ-123. Analysis of the binding data with endothelium-intact samples yielded two classes of binding sites in both women and men. In women, the maximum binding capacities were 83 +/- 6 and 97 +/- 10 fmol/mg protein for ETA and ETB receptors, respectively; the corresponding values in men were 618 +/- 121 and 201 +/- 10 fmol/mg protein. In addition, ET-1-induced contractions were 2-fold greater in men than in women at high ET-1 concentrations. Competitive binding studies with endothelium-denuded saphenous veins demonstrated the presence of only ETA receptors in both female and male tissue. These results indicate that the ratio and the density of ET receptors are different in men and women, which might be an important factor in the regulation of the contractile response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580591

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

1.  Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance.

Authors:  A Ergul; C Joffs; A C Walker; F G Spinale
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance.

Authors:  S S Jarvis; J P Florian; M J Curren; J A Pawelczyk
Journal:  J Appl Physiol (1985)       Date:  2012-02-16

3.  Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

4.  Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Sandeep Jandu; Lakshmi Santhanam; Lacy M Alexander
Journal:  Clin Sci (Lond)       Date:  2017-11-23       Impact factor: 6.124

5.  ETB receptor contribution to vascular dysfunction in postmenopausal women.

Authors:  Megan M Wenner; Kelly N Sebzda; Andrew V Kuczmarski; Ryan T Pohlig; David G Edwards
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-24       Impact factor: 3.619

Review 6.  Sex Differences in Cardiovascular Aging and Heart Failure.

Authors:  Andrew Oneglia; Michael D Nelson; C Noel Bairey Merz
Journal:  Curr Heart Fail Rep       Date:  2020-09-28

Review 7.  Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females.

Authors:  Ellen E Gillis; Jennifer M Sasser; Jennifer C Sullivan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-02       Impact factor: 3.619

Review 8.  Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.

Authors:  Eman Y Gohar; Fernanda R Giachini; David M Pollock; Rita C Tostes
Journal:  Life Sci       Date:  2016-03-03       Impact factor: 5.037

Review 9.  Hypertension: what's sex got to do with it?

Authors:  Margaret A Zimmerman; Jennifer C Sullivan
Journal:  Physiology (Bethesda)       Date:  2013-07

Review 10.  GPCRs in context: sexual dimorphism in the cardiovascular system.

Authors:  Margaret A Mouat; James L J Coleman; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2018-03-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.